• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

作者信息

Muller Yannick D, Aubert John-David, Vionnet Julien, Rotman Samuel, Sadallah Salima, Aubert Vincent, Pascual Manuel

机构信息

Transplantation Center, Lausanne University Hospital, University of Lausanne, Switzerland.

Service of Pneumology, Lausanne University Hospital, University of Lausanne, Switzerland.

出版信息

Transplantation. 2018 Jun;102(6):e301-e303. doi: 10.1097/TP.0000000000002165.

DOI:10.1097/TP.0000000000002165
PMID:29521880
Abstract
摘要

相似文献

1
Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.肺移植术后1周急性抗体介导的排斥反应经依库珠单抗、静脉注射免疫球蛋白和利妥昔单抗成功治疗
Transplantation. 2018 Jun;102(6):e301-e303. doi: 10.1097/TP.0000000000002165.
2
Outcomes of combination therapy including rituximab for antibody-mediated rejection after lung transplantation.肺移植后包括利妥昔单抗在内的联合治疗用于抗体介导性排斥反应的疗效。
Gen Thorac Cardiovasc Surg. 2020 Feb;68(2):142-149. doi: 10.1007/s11748-019-01189-1. Epub 2019 Aug 21.
3
Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.使用抗胸腺细胞球蛋白（ATG）单药治疗以及利妥昔单抗、静脉注射免疫球蛋白和血浆置换联合治疗活检证实的急性抗体介导排斥反应：从初步经验中获得的教训
Clin Transpl. 2014:223-30.
4
Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports.依库珠单抗治疗肾移植急性抗体介导的排斥反应：病例报告
Transplant Proc. 2012 Nov;44(9):2690-4. doi: 10.1016/j.transproceed.2012.09.038.
5
Early Versus Late Acute Antibody-Mediated Rejection Among Renal Transplant Recipients in Terms of Response to Rituximab Therapy: A Single Center Experience.肾移植受者中早期与晚期急性抗体介导排斥反应对利妥昔单抗治疗的反应：单中心经验
Exp Clin Transplant. 2017 Feb;15(Suppl 1):150-155. doi: 10.6002/ect.mesot2016.P32.
6
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis.抗体介导的排斥反应在肾移植中的治疗：一项更新的系统评价和荟萃分析。
Transplantation. 2018 Apr;102(4):557-568. doi: 10.1097/TP.0000000000002049.
7
[Role of antibodies in kidney transplant].[抗体在肾移植中的作用]
G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S54-60.
8
Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?抗体清除策略治疗肺移植受者疑似抗体介导的排斥反应：是否有效？
Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12886. Epub 2017 Feb 1.
9
Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children.供体特异性抗HLA抗体及抗体介导的排斥反应对儿童小肠移植术后结局的影响。
Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12847. Epub 2017 Jan 13.
10
Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients: Single-Center Experience.肾移植受者慢性活动性抗体介导排斥反应的管理：单中心经验
Exp Clin Transplant. 2019 Jan;17(Suppl 1):113-119. doi: 10.6002/ect.MESOT2018.O58.

引用本文的文献

1
Pushing the Survival Bar Higher: Two Decades of Innovation in Lung Transplantation.提高生存几率：肺移植二十年创新历程
J Clin Med. 2024 Sep 18;13(18):5516. doi: 10.3390/jcm13185516.
2
Antibody-Mediated Rejection in Lung Transplantation: Diagnosis and Therapeutic Armamentarium in a 21st Century Perspective.抗体介导的肺移植排斥反应：21 世纪视角下的诊断和治疗策略。
Transpl Int. 2024 Aug 7;37:12973. doi: 10.3389/ti.2024.12973. eCollection 2024.
3
Management of donor-specific antibodies in lung transplantation.肺移植中供者特异性抗体的管理
Front Transplant. 2023 Sep 29;2:1248284. doi: 10.3389/frtra.2023.1248284. eCollection 2023.
4
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.视神经脊髓炎谱系疾病（NMOSD）的诊断和治疗进展——视神经脊髓炎研究组（NEMOS）的修订建议。第二部分：发作期治疗和长期管理。
J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7.
5
Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?异种移植中的抗体介导排斥反应：能否预防或逆转？
Xenotransplantation. 2023 Jul-Aug;30(4):e12816. doi: 10.1111/xen.12816. Epub 2023 Aug 7.
6
Current perspective of immunomodulators for lung transplant.肺移植免疫调节剂的当前观点
Indian J Thorac Cardiovasc Surg. 2022 Sep;38(5):497-505. doi: 10.1007/s12055-022-01388-1. Epub 2022 Jul 14.
7
B Cell Immunity in Lung Transplant Rejection - Effector Mechanisms and Therapeutic Implications.肺移植排斥反应中的B细胞免疫——效应机制及治疗意义
Front Immunol. 2022 Mar 7;13:845867. doi: 10.3389/fimmu.2022.845867. eCollection 2022.
8
Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.依库珠单抗阻断补体治疗心脏移植后急性症状性体液排斥反应。
Xenotransplantation. 2022 Jan;29(1):e12726. doi: 10.1111/xen.12726. Epub 2022 Jan 10.
9
Immunosuppression in Lung Transplantation.肺移植中的免疫抑制。
Handb Exp Pharmacol. 2022;272:139-164. doi: 10.1007/164_2021_548.
10
Antibody-mediated rejection after lung transplantation.肺移植术后抗体介导的排斥反应。
Ann Transl Med. 2020 Mar;8(6):411. doi: 10.21037/atm.2019.11.86.